Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros













Intervalo de año de publicación
1.
J Invest Surg ; 32(3): 238-244, 2019 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29589984

RESUMEN

Purpose/Aim of the study: Inflammation and oxidative stress are two significant factors affecting the degree of liver damage in obstructive jaundice. The aim of this study was to evaluate the effect of calcium dobesilate (CaDob), an effective antioxidant and anti-inflammatory drug, on damage to liver caused by experimental obstructive jaundice. MATERIALS AND METHODS: 30 rats in total were randomly placed into three groups, each group consisting of 10 rats. The sham group (Group 1) only received solely laparotomy. In the control group (Group 2), ligation was applied to the biliary tract and no treatment was implemented. In the CaDob group (Group 3), following ligation of the biliary tract, 100 mg/kg/day CaDob was implemented via an orogastric tube for a 10-day period. Liver tissue and blood samples were taken for histopathological and biochemical examination. RESULTS: The CaDob group had significantly lower test values for serum liver functions when compared to the control group. Statistically lower levels of tissue malondialdehyde (MDA) and fluorescent oxidation products (FOP) were detected in the CaDob group, and the CaDob group had significantly higher levels of sulfydryl (SH) than the control group. Histopathological scores in the CaDob group were found out to be statistically less than the scores the control group received (p < 0.05). CONCLUSIONS: CaDob treatment repaired the histpatological changes induced by bile duct ligation. The hepatoprotective effects of CaDob can be associated with its antioxidant properties of the drug.


Asunto(s)
Antioxidantes/farmacología , Dobesilato de Calcio/farmacología , Ictericia Obstructiva/tratamiento farmacológico , Hígado/efectos de los fármacos , Animales , Antioxidantes/uso terapéutico , Dobesilato de Calcio/uso terapéutico , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Femenino , Humanos , Ictericia Obstructiva/etiología , Ictericia Obstructiva/patología , Hígado/patología , Hígado/fisiopatología , Pruebas de Función Hepática , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Wistar , Resultado del Tratamiento
2.
Acta Cir Bras ; 33(7): 565-576, 2018 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-30110058

RESUMEN

PURPOSE: To investigate the possible effects of argan oil on the healing of colorectal anastomoses. METHODS: n Group 1 (sham), laparotomy was performed and the colon was mobilized. In the control (Group 2) and argan oil (Group 3) groups, colonic resection and anastomosis were applied. To the control and sham groups, 2 mL of 0.9% NaCl was administred rectally, and in the argan oil group, 2 mL/day argan oil was applied rectally for 7 days. RESULTS: The mean bursting pressures of the argan oil and sham groups were significantly higher than the values in the control group. A significant difference was determined between the tissue hydroxyproline and prolidase levels of control group and other groups. Histopathologically, argan oil showed significant beneficial effects on colonic wound healing. In the argan oil and sham groups, the tissue malondialdehyde and fluorescent oxidation product levels were found to be lower and total sulfhydryl levels were higher than the control group. CONCLUSIONS: The rectally administered argan oil was observed to have significantly ameliorated wound healing parameters and exerted a significant antioxidant effect. This is the first study in the literature about the beneficial effects of argan oil on colorectal anastomoses.


Asunto(s)
Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Colon/cirugía , Aceites de Plantas/uso terapéutico , Recto/cirugía , Cicatrización de Heridas/efectos de los fármacos , Anastomosis Quirúrgica , Animales , Colágeno/análisis , Colon/patología , Dipeptidasas/análisis , Femenino , Hidroxiprolina/análisis , Malondialdehído/análisis , Estrés Oxidativo/efectos de los fármacos , Oxidorreductasas/análisis , Distribución Aleatoria , Ratas Wistar , Recto/patología , Reproducibilidad de los Resultados , Espectrofotometría , Herida Quirúrgica/tratamiento farmacológico , Herida Quirúrgica/patología , Resultado del Tratamiento
3.
Acta cir. bras ; 33(7): 565-576, July 2018. tab, graf
Artículo en Inglés | LILACS | ID: biblio-949365

RESUMEN

Abstract Purpose: To investigate the possible effects of argan oil on the healing of colorectal anastomoses. Methods: I n Group 1 (sham), laparotomy was performed and the colon was mobilized. In the control (Group 2) and argan oil (Group 3) groups, colonic resection and anastomosis were applied. To the control and sham groups, 2 mL of 0.9% NaCl was administred rectally, and in the argan oil group, 2 mL/day argan oil was applied rectally for 7 days. Results: The mean bursting pressures of the argan oil and sham groups were significantly higher than the values in the control group. A significant difference was determined between the tissue hydroxyproline and prolidase levels of control group and other groups. Histopathologically, argan oil showed significant beneficial effects on colonic wound healing. In the argan oil and sham groups, the tissue malondialdehyde and fluorescent oxidation product levels were found to be lower and total sulfhydryl levels were higher than the control group. Conclusions: The rectally administered argan oil was observed to have significantly ameliorated wound healing parameters and exerted a significant antioxidant effect. This is the first study in the literature about the beneficial effects of argan oil on colorectal anastomoses.


Asunto(s)
Animales , Femenino , Recto/cirugía , Cicatrización de Heridas/efectos de los fármacos , Aceites de Plantas/uso terapéutico , Colon/cirugía , Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Oxidorreductasas/análisis , Recto/patología , Espectrofotometría , Anastomosis Quirúrgica , Distribución Aleatoria , Reproducibilidad de los Resultados , Colágeno/análisis , Resultado del Tratamiento , Ratas Wistar , Colon/patología , Estrés Oxidativo/efectos de los fármacos , Dipeptidasas/análisis , Herida Quirúrgica/patología , Herida Quirúrgica/tratamiento farmacológico , Hidroxiprolina/análisis , Malondialdehído/análisis
4.
Biomed Pharmacother ; 96: 968-973, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29198926

RESUMEN

The purpose of this experimental study was to evaluate the potential effects on the healing of colorectal anastomoses of the rectal administration of Ankaferd Blood Stopper (ABS). Thirty Wistar-Albino male rats were randomly separated into 3 groups. In the sham group, only laparotomy and colonic mobilization was performed. In the other 2 groups, colon transection and anastomosis were carried out. Saline (2 mL, 0.9% NaCl) was given rectally via a feeding tube for 10 days after the surgical procedure in the sham and control groups. In Group 3 (ABS group), the rats were treated with rectally administered ABS (2 mL/day) for 10 days. In all groups, after the measurement of bursting pressures, tissue samples were collected for the measurement of tissue hydroxyproline and prolidase levels, and for histopathological evaluation on postoperative day 11. The rectal administration of ABS showed positive effects on bursting pressures, tissue prolidase and hydroxyproline levels, and the histopathological findings of colonic anastomosis. The rectal application of ABS had positive effects on the healing of colorectal anastomosis. As a natural product, it may be used effectively and safely to achieve better healing results after colorectal anastomosis.


Asunto(s)
Fuga Anastomótica/tratamiento farmacológico , Colon/efectos de los fármacos , Extractos Vegetales/administración & dosificación , Recto/metabolismo , Cicatrización de Heridas/efectos de los fármacos , Anastomosis Quirúrgica/métodos , Fuga Anastomótica/metabolismo , Animales , Colon/metabolismo , Hidroxiprolina/metabolismo , Masculino , Ratas , Ratas Wistar
5.
Acta Cir Bras ; 32(10): 796-806, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29160366

RESUMEN

PURPOSE: To investigate the potential protective effects of erdosteine against the harmful effects of ischemia-reperfusion injury on the liver in an experimental rat model. METHODS: Forty rats were divided into 4 groups. In the sham group, only the hepatic pedicle was mobilized. No other manipulation or treatment was performed. In the other groups, ischemia was achieved by clamping the hepatic pedicle for 60 min. After that, 90 min reperfusion was provided. In the control group, no treatment was given. In the perioperative treatment group, 100 mg/kg erdosteine was administered 2 hours before ischemia induction. In the preoperative treatment group, 100 mg/kg/day erdosteine was administered daily for ten days before the operation. At the end of the procedures, blood and liver samples were obtained for biochemical and histopathological assessment. RESULTS: Treatment with erdosteine ameliorated the histopathological abnormalities when compared with the control group. Furthermore, this treatment significantly decreased the serum liver function test values. It was also found that erdosteine ameliorated the oxidative stress parameters in both the perioperative and preoperative treatment groups. CONCLUSION: The current study is the first to have shown the favorable effects of erdosteine on the harmful effects of experimental hepatic ischemia-reperfusion injury.


Asunto(s)
Hígado/irrigación sanguínea , Sustancias Protectoras/administración & dosificación , Daño por Reperfusión/tratamiento farmacológico , Tioglicolatos/administración & dosificación , Tiofenos/administración & dosificación , Animales , Modelos Animales de Enfermedad , Femenino , Hígado/patología , Ratas , Ratas Wistar
6.
Acta cir. bras ; 32(10): 796-806, Oct. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-886176

RESUMEN

Abstract Purpose: To investigate the potential protective effects of erdosteine against the harmful effects of ischemia-reperfusion injury on the liver in an experimental rat model. Methods: Forty rats were divided into 4 groups. In the sham group, only the hepatic pedicle was mobilized. No other manipulation or treatment was performed. In the other groups, ischemia was achieved by clamping the hepatic pedicle for 60 min. After that, 90 min reperfusion was provided. In the control group, no treatment was given. In the perioperative treatment group, 100 mg/kg erdosteine was administered 2 hours before ischemia induction. In the preoperative treatment group, 100 mg/kg/day erdosteine was administered daily for ten days before the operation. At the end of the procedures, blood and liver samples were obtained for biochemical and histopathological assessment. Results: Treatment with erdosteine ameliorated the histopathological abnormalities when compared with the control group. Furthermore, this treatment significantly decreased the serum liver function test values. It was also found that erdosteine ameliorated the oxidative stress parameters in both the perioperative and preoperative treatment groups. Conclusion: The current study is the first to have shown the favorable effects of erdosteine on the harmful effects of experimental hepatic ischemia-reperfusion injury.


Asunto(s)
Animales , Femenino , Ratas , Tioglicolatos/administración & dosificación , Tiofenos/administración & dosificación , Daño por Reperfusión/tratamiento farmacológico , Sustancias Protectoras/administración & dosificación , Hígado/irrigación sanguínea , Ratas Wistar , Modelos Animales de Enfermedad , Hígado/patología
7.
Acta Cir Bras ; 31(11): 736-743, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-27982261

RESUMEN

PURPOSE:: To investigate the potential protective effects of enoxaparin against the adverse events of carbon dioxide (CO2) pneumoperitoneum. METHODS:: Thirty four rats were divided into three groups: Group 1 (sham) underwent insertion of Veress needle into the abdomen and 90 min of anesthesia with no gas insufflation. The animals in control and enoxaparin groups were subjected to 90 min of 14 mmHg CO2 pneumoperitoneum. Enoxaparin (100 u/kg) was administered subcutaneously to the rats in enoxaparin group one hour before the operation. After 90 min of pneumoperitoneum, the rats were allowed for reperfusion through 60 min. Blood and liver samples were obtained for biochemical and histopathological examination. RESULTS:: Treatment with enoxaparin decreased the histopathological abnormalities when compared with the control group. The highest levels of oxidative stress parameters were found in control group. The use of enoxaparin decreased the levels of all oxidative stress parameters, but the difference between the control and enoxaparin groups was not statistically significant. CONCLUSION:: Enoxaparin ameliorated the harmful effects of high pressure CO2 pneumoperitoneum on the liver.


Asunto(s)
Anticoagulantes/uso terapéutico , Dióxido de Carbono/efectos adversos , Enoxaparina/uso terapéutico , Hígado/efectos de los fármacos , Oxígeno/administración & dosificación , Neumoperitoneo Artificial/efectos adversos , Animales , Dióxido de Carbono/administración & dosificación , Modelos Animales de Enfermedad , Femenino , Hígado/patología , Estrés Oxidativo/fisiología , Neumoperitoneo Artificial/métodos , Presión , Ratas , Ratas Wistar , Tromboembolia/prevención & control
8.
Acta cir. bras ; 31(11): 736-743, Nov. 2016. tab, graf
Artículo en Inglés | LILACS | ID: biblio-827666

RESUMEN

ABSTRACT PURPOSE: To investigate the potential protective effects of enoxaparin against the adverse events of carbon dioxide (CO2) pneumoperitoneum. METHODS: Thirty four rats were divided into three groups: Group 1 (sham) underwent insertion of Veress needle into the abdomen and 90 min of anesthesia with no gas insufflation. The animals in control and enoxaparin groups were subjected to 90 min of 14 mmHg CO2 pneumoperitoneum. Enoxaparin (100 u/kg) was administered subcutaneously to the rats in enoxaparin group one hour before the operation. After 90 min of pneumoperitoneum, the rats were allowed for reperfusion through 60 min. Blood and liver samples were obtained for biochemical and histopathological examination. RESULTS: Treatment with enoxaparin decreased the histopathological abnormalities when compared with the control group. The highest levels of oxidative stress parameters were found in control group. The use of enoxaparin decreased the levels of all oxidative stress parameters, but the difference between the control and enoxaparin groups was not statistically significant. CONCLUSION: Enoxaparin ameliorated the harmful effects of high pressure CO2 pneumoperitoneum on the liver.


Asunto(s)
Animales , Femenino , Ratas , Oxígeno/administración & dosificación , Neumoperitoneo Artificial/efectos adversos , Dióxido de Carbono/efectos adversos , Enoxaparina/uso terapéutico , Hígado/efectos de los fármacos , Anticoagulantes/uso terapéutico , Neumoperitoneo Artificial/métodos , Presión , Tromboembolia/prevención & control , Dióxido de Carbono/administración & dosificación , Ratas Wistar , Estrés Oxidativo/fisiología , Modelos Animales de Enfermedad , Hígado/patología
9.
J Invest Surg ; 24(5): 211-6, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21867390

RESUMEN

INTRODUCTION: This study was established to assess the effects of low dose enoxaparin on plasma malondialdehyde levels during laparoscopic cholecystectomy as a model of ischemia-reperfusion. MATERIALS AND METHODS: Fifty patients, scheduled for laparoscopic cholecystectomy, were randomized into two groups of 25 patients in each. In enoxaparin group, patients had 20 mg/0.2 ml subcutaneous (sc) enoxaparin 2 hr before surgery. Blood samples were obtained for malondialdehyde, alanine transferase, aspartate transferase, measurements before the insufflation, 1 min before deflation, and 20 min after deflation. RESULTS: Plasma malondialdehyde concentrations were insignificant between enoxaparin and control groups before insufflation (1.64 ± 2.66 vs. 2.45 ± 4.42 µmol l(-1); p = 0.44) and 1 min before deflation (1.55 ± 2.61 vs. 3.66 ± 5.68 µmol l(-1); p = 0.38). Malondialdehyde levels significantly increased in control group 20 min after deflation in respect to enoxaparin group (1.52 ± 2.67 vs. 6.04 ± 7.85 µmol l(-1)), (p = 0.049). In control group, plasma malondialdehyde concentrations increased significantly compared with initial level throughout the study (p = 0.001). Within enoxaparin group, no statistically significant change was observed (p = 0.28). Plasma alanine transferase and aspartate transferase levels increased similarly in both groups during the study (p > 0.05). Alanine transferase and aspartate transferase increases within each group were statistically significant for all times (p < 0.05). DISCUSSION AND CONCLUSIONS: As a conclusion, mini dose of enoxaparin used sc'ly 2 hr before the operation, prevented the malondialdehyde increase during reperfusion period after laparoscopic cholecystectomy without causing any bleeding disorder while having no effect on serum alanine transferase, aspartate transferase increase.


Asunto(s)
Enoxaparina/uso terapéutico , Malondialdehído/sangre , Daño por Reperfusión/prevención & control , Adulto , Anciano , Alanina Transaminasa/sangre , Aspartato Aminotransferasas/sangre , Colecistectomía Laparoscópica/métodos , Humanos , Persona de Mediana Edad
10.
Ophthalmologica ; 221(4): 264-8, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17579293

RESUMEN

AIMS: To evaluate preoperative and postoperative conjunctival surface changes in multinodular goiter (MNG) patients and to compare their results with healthy control subjects. METHODS: Twenty MNG patients who had undergone near total thyroidectomy were evaluated pre- and postoperatively at the end of the 3rd month and the 1st year by performing tear function tests and conjunctival impression cytologic analysis. These results were compared with the results of 15 healthy volunteers. RESULTS: When preoperative and postoperative tear function parameters were compared, the mean Schirmer test value and BUT value were decreased, the mean Rose Bengal staining score was increased during the postoperative period. These differences were statistically significant at the end of the 1st year (p < 0.001). The average goblet cell density of the MNG patients decreased significantly during the postoperative period when compared with the preoperative values (p < 0.001). All these findings of the MNG cases were significantly different from the results of the control group both before and after the operation. CONCLUSION: Tear function tests and the impression cytology findings of the MNG cases were statistically different from the results of the control group during the pre- and postoperative period. We recommend postoperative follow-up of these patients for ocular surface changes.


Asunto(s)
Conjuntiva/fisiopatología , Bocio Nodular/fisiopatología , Lágrimas/fisiología , Adolescente , Adulto , Anciano , Recuento de Células , Femenino , Células Caliciformes/patología , Bocio Nodular/cirugía , Humanos , Masculino , Persona de Mediana Edad , Tiroidectomía , Tirotropina/sangre , Tiroxina/sangre , Triyodotironina/sangre
11.
J Invest Surg ; 16(4): 233-7, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-12893500

RESUMEN

We investigated the possible use of D-lactate as a predictor in the diagnosis of appendicitis. C-reactive protein level (CRP) and leukocyte counts were also evaluated. Venous blood D-lactate, CRP, and leukocyte counts were measured preoperatively in 53 patients undergoing surgery for appendicitis, as well as in 20 healthy subjects. Levels of all three parameters in the surgical patients were significantly higher than in the control group (p <.05). Previous studies have shown that venous D-lactate is more specific to the intestine than CPR or leukocyte count. Based on our data, venous D-lactate, which had the lowest false-negative rate among these laboratory parameters, may be a useful diagnostic marker for appendicitis. None of these parameters were helpful in identifying the type of the appendicitis.


Asunto(s)
Apendicitis/sangre , Apendicitis/diagnóstico , Ácido Láctico/sangre , Enfermedad Aguda , Adolescente , Adulto , Biomarcadores , Proteína C-Reactiva/metabolismo , Niño , Humanos , Recuento de Leucocitos , Persona de Mediana Edad , Valor Predictivo de las Pruebas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA